January 2026
VisionMed partnered in an IRB-approved study evaluating AI applications in surgeon training for robotic surgery.
December 2025
A VisionMed technical leader spoke at the Ideagen Global Leadership Summit at NASDAQ, participating in discussions on enterprise AI adoption, healthcare collaboration, and information security.
October 2025
VisionMed initiated a collaboration with a global robotic surgery society to support training, education, and research initiatives using AI‑enabled procedural video analysis.
October 2025
VisionMed participated in industry leadership forums focused on AI in healthcare, including delivering the closing talk at a Google‑hosted AI & Agents for Healthcare event on AI agents in clinical applications.
June 2025
VisionMed announced the appointment of Dr. Frantz Lerebours, MD, an orthopedic surgeon, as a clinical advisor to support procedural workflow and validation initiatives.
April 2025
VisionMed announced initial commercial availability of its procedural documentation and analytics platform, EMMA™, with early evaluations underway across select clinical environments.
April 2025
VisionMed exhibited at the International College of Surgeons Annual Meeting, marking the company’s first medical conference exhibition.